Analysts Set R1 RCM Inc. (NASDAQ:RCM) Target Price at $15.73

R1 RCM Inc. (NASDAQ:RCM) has been given a consensus rating of “Hold” by the seventeen ratings firms that are presently covering the company, MarketBeat.com reports. Twelve equities research analysts have rated the stock with a hold recommendation and five have issued a buy recommendation on the company. The average 12-month price objective among brokerages that have updated their coverage on the stock in the last year is $15.73.

Separately, Cantor Fitzgerald reissued a “neutral” rating and issued a $14.30 price target on shares of R1 RCM in a report on Friday, October 4th.

Hedge Funds Weigh In On R1 RCM

A number of hedge funds have recently added to or reduced their stakes in RCM. GAMMA Investing LLC grew its holdings in shares of R1 RCM by 41.3% during the third quarter. GAMMA Investing LLC now owns 2,597 shares of the healthcare provider’s stock valued at $37,000 after purchasing an additional 759 shares during the last quarter. Allspring Global Investments Holdings LLC boosted its position in R1 RCM by 589.2% during the 3rd quarter. Allspring Global Investments Holdings LLC now owns 3,122 shares of the healthcare provider’s stock valued at $44,000 after purchasing an additional 2,669 shares during the period. ANTIPODES PARTNERS Ltd bought a new position in R1 RCM during the 2nd quarter worth $86,000. Values First Advisors Inc. acquired a new stake in R1 RCM in the third quarter worth $88,000. Finally, Creative Planning bought a new stake in R1 RCM in the third quarter valued at $142,000. Institutional investors and hedge funds own 61.10% of the company’s stock.

R1 RCM Trading Up 0.1 %

NASDAQ RCM opened at $14.31 on Monday. The stock has a market cap of $6.04 billion, a P/E ratio of -95.39 and a beta of 0.84. The company’s fifty day simple moving average is $14.28 and its 200-day simple moving average is $13.70. The company has a current ratio of 1.79, a quick ratio of 1.79 and a debt-to-equity ratio of 0.76. R1 RCM has a 52 week low of $8.87 and a 52 week high of $15.12.

R1 RCM (NASDAQ:RCM) last issued its quarterly earnings data on Tuesday, November 5th. The healthcare provider reported ($0.05) EPS for the quarter, missing analysts’ consensus estimates of ($0.01) by ($0.04). The firm had revenue of $656.80 million during the quarter, compared to analyst estimates of $640.93 million. R1 RCM had a negative return on equity of 2.18% and a negative net margin of 2.48%. The company’s quarterly revenue was up 14.7% on a year-over-year basis. Equities research analysts predict that R1 RCM will post -0.18 EPS for the current fiscal year.

R1 RCM Company Profile

R1 RCM Inc provides technology-driven solutions for the financial performance and patient experience of health systems, hospitals, and physician groups. It provides operating partnership/end-to-end solutions, which manages multiple aspects of the revenue cycle to realize financial leverage and revenue improvement for hospital and physician customers.